Wednesday and Thursday this week were two strong trading days for Evotec shares, which fell sharply. However, the recovery, which peaked at EUR 17.365 yesterday, started at the bottom of the bear market at EUR 15.77 and thus compensated only a fraction of the price losses of the shares of the Hamburg biotech company since September 2021 and prices above EUR 5. For now, however, it is important to look ahead and ask: is there still work to be done? A look at the biotech stock’s chart shows a breach of the 17.00/17.19 euro limits, which is still strengthening despite a slightly softer trend this morning. For Evotec shares (WKN: 566 80, ISIN: DE000566 809, chart), Tradegate’s bid-ask spread is currently 17,220/17,335 euros. Yesterday, the TecDAX value of XETRA finished trading at EUR 17.35, which is almost the maximum of the day.